Cargando…
Blood Leukocyte AHRR Methylation and Risk of Non–smoking-associated Cancer: A Case-cohort Study of Non–Hodgkin Lymphoma
Aryl-hydrocarbon receptor repressor (AHRR) hypomethylation in peripheral blood is tightly linked with tobacco smoking and lung cancer. Here, we investigated AHRR methylation in non–Hodgkin lymphoma (NHL), a non–smoking-associated cancer. In a case-cohort study within the population-based Danish Diet...
Autores principales: | Dahl, Christina, Hvidtfeldt, Ulla A., Tjønneland, Anne, Guldberg, Per, Raaschou-Nielsen, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484117/ https://www.ncbi.nlm.nih.gov/pubmed/37691855 http://dx.doi.org/10.1158/2767-9764.CRC-23-0151 |
Ejemplares similares
-
A Prospective Study of Organochlorines in Adipose Tissue and Risk of Non-Hodgkin Lymphoma
por: Bräuner, Elvira Vaclavik, et al.
Publicado: (2011) -
Residential Exposure to PM(2.5) Components and Risk of Childhood Non-Hodgkin Lymphoma in Denmark: A Nationwide Register-Based Case-Control Study
por: Hvidtfeldt, Ulla Arthur, et al.
Publicado: (2020) -
AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival
por: Kemp Jacobsen, Katja, et al.
Publicado: (2019) -
Methylation at cg05575921 of a smoking-related gene (AHRR) in non-smoking Taiwanese adults residing in areas with different PM(2.5) concentrations
por: Tantoh, Disline Manli, et al.
Publicado: (2019) -
AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality
por: Grieshober, Laurie, et al.
Publicado: (2020)